Capricor Therapeutics | CAPR - Ordinary Share Capital


Capricor Therapeutics reported $57.37M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Bioline Rx USD 2.61B 53.2M Sep/2025
Capricor Therapeutics USD 57.37M 11.65M Dec/2025
Cipla INR 807.77M 807.43M Sep/2025
Cytokinetics USD 122.26M 145K Dec/2025
Geron USD 638.36M 338K Dec/2025
Grifols EUR 680.58M 846.11K Dec/2025
Immunic USD 120.38M 21.73M Dec/2025
J&J USD 2.41B 1.74M Dec/2025
Plus Therapeutics USD 138.68M 7.07M Dec/2025
Prothena USD 53.83M 3K Dec/2025
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Sarepta Therapeutics USD 104.96M 196K Dec/2025